gastric cancer

Research Reports
Patterns and Predictors of Treatment Choice in a Real-World Cohort of Patients with Metastatic Gastric Cancer in the United States
09/22/2021
Thomas A. Abrams, MD, and colleagues examine patterns of systemic therapy administration in metastatic gastric cancer and the predictors associated with specific treatment choices.
Thomas A. Abrams, MD, and colleagues examine patterns of systemic therapy administration in metastatic gastric cancer and the predictors associated with specific treatment choices.
Thomas A. Abrams, MD, and...
09/22/2021
Journal of Clinical Pathways
NCCN Updates Clinical Practice Guideline for Gastric Cancer
NCCN Updates Clinical Practice Guideline for Gastric Cancer
03/10/2021
The National Comprehensive Cancer Network released an update to its clinical practice guideline for gastric cancer.
The National Comprehensive Cancer Network released an update to its clinical practice guideline for gastric cancer.
The National Comprehensive...
03/10/2021
Journal of Clinical Pathways
News
First-Line Biosimilar-Based Triplet Effective in HER2-Positive Gastric Cancer
07/08/2020
A first-line triplet regimen consisting of pembrolizumab, biosimilar trastuzumab (Herzuma), and chemotherapy is effective in patients with HER2-positive advanced gastric cancer, according to the results of a phase...
A first-line triplet regimen consisting of pembrolizumab, biosimilar trastuzumab (Herzuma), and chemotherapy is effective in patients with HER2-positive advanced gastric cancer, according to the results of a phase...
A...
07/08/2020
Journal of Clinical Pathways
News
Deep Learning Model Accurately Predicts Risk of OS in Gastric Cancer
06/22/2020
A novel deep learning model may accurately predict the risk for overall survival (OS) based on computed tomography (CT) images. Improved risk prediction of OS in gastric cancer is needed in order to guide...
A novel deep learning model may accurately predict the risk for overall survival (OS) based on computed tomography (CT) images. Improved risk prediction of OS in gastric cancer is needed in order to guide...
A...
06/22/2020
Journal of Clinical Pathways
Research in Review
Post-Surgery Complications for Gastric Cancer Significantly Raise Hospital Costs
06/29/2017
JCP Editors
Major complications following total gastrectomy for gastric adenocarcinoma can triple the amount of standard hospital costs, according to research published in JAMA Surgery (published online June 28, 2017;...
Major complications following total gastrectomy for gastric adenocarcinoma can triple the amount of standard hospital costs, according to research published in JAMA Surgery (published online June 28, 2017;...
Major...
06/29/2017
Journal of Clinical Pathways
Research in Review
Higher Dose Does Not Improve Efficacy of Gastric Cancer Treatment
06/20/2017
JCP Editors
A higher dose treatment for a type of metastatic gastric adenocarcinoma showed equivalent efficacy and safety, according to research published in the Journal of Clinical Oncology (published online June 2017;...
A higher dose treatment for a type of metastatic gastric adenocarcinoma showed equivalent efficacy and safety, according to research published in the Journal of Clinical Oncology (published online June 2017;...
A...
06/20/2017
Journal of Clinical Pathways
Clinical Pathways for Advance Stage Gastric Cancer: Standardizing Practice to Decrease Variability and Improve Outcomes
06/13/2017
EXECUTIVE SUMMARY Gastric cancer is the fifth most diagnosed cancer worldwide and the third leading cause of cancer deaths. In the United States and other countries with low rates of gastric cancer, the population...
EXECUTIVE SUMMARY Gastric cancer is the fifth most diagnosed cancer worldwide and the third leading cause of cancer deaths. In the United States and other countries with low rates of gastric cancer, the population...
...
06/13/2017
Journal of Clinical Pathways
Research in Review
Type of Low-Grade Tumor Commonly Over-Diagnosed, Study Suggests
06/12/2017
JCP Editors
A recent study showed that over 65% of cases of a certain tumor type were over-diagnosed or inaccurately risk-stratified, published in PLOS One (June 7, 2017;12[6]:e0179216). ----- Related Content Modified...
A recent study showed that over 65% of cases of a certain tumor type were over-diagnosed or inaccurately risk-stratified, published in PLOS One (June 7, 2017;12[6]:e0179216). ----- Related Content Modified...
A...
06/12/2017
Journal of Clinical Pathways
Research in Review
MicroRNA a Novel Biomarker for Gastric Cancer
10/12/2016
JCP Editors
Serum microRNA-206 (miRNA) may serve as not only a novel diagnostic biomarker for gastric cancer but also as an indicator of prognosis and cancer recurrence, according to a study published in Cellular Physiology and...
Serum microRNA-206 (miRNA) may serve as not only a novel diagnostic biomarker for gastric cancer but also as an indicator of prognosis and cancer recurrence, according to a study published in Cellular Physiology and...
Serum...
10/12/2016
Journal of Clinical Pathways
Research in Review
Among European Nations, Greater Clinical Standardization Needed for Patients With Cancer
03/08/2016
JCP Editors
A questionnaire issued to experts in 14 European countries that use oncology clinical pathways has identified the need for greater standardization of clinical practices for patients with esophageal and gastric...
A questionnaire issued to experts in 14 European countries that use oncology clinical pathways has identified the need for greater standardization of clinical practices for patients with esophageal and gastric...
...
03/08/2016
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use